187 related articles for article (PubMed ID: 28263922)
21. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
22. [Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation].
Liu QF; Luo XD; Fan ZP; Ning J; Xu D; Sun J; Zhang Y; Xu B; Wei YQ
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):538-42. PubMed ID: 19567075
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
[TBL] [Abstract][Full Text] [Related]
24. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
[TBL] [Abstract][Full Text] [Related]
25. Association between IL1B (+3954) polymorphisms and IL-1β levels in blood and saliva, together with acute graft-versus-host disease.
Resende RG; Abreu MH; de Souza LN; Silva ME; Gomez RS; Correia-Silva Jde F
J Interferon Cytokine Res; 2013 Jul; 33(7):392-7. PubMed ID: 23659674
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
27. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Pérez-Simón JA; Díez-Campelo M; Martino R; Brunet S; Urbano A; Caballero MD; de León A; Valcárcel D; Carreras E; del Cañizo MC; López-Fidalgo J; Sierra J; San Miguel JF
Br J Haematol; 2005 Aug; 130(3):394-403. PubMed ID: 16042689
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
[TBL] [Abstract][Full Text] [Related]
29. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
30. [Changes of IL-2, IL-8, IL-10 and TNF-alpha levels in sera of patients with acute graft-versus-host disease].
Wang SH; Da WM; Jin HJ; Jing Y; Yan GT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):755-8. PubMed ID: 16928315
[TBL] [Abstract][Full Text] [Related]
31. Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation.
Martínez-Bravo MJ; Calderón-Cabrera C; Márquez-Malaver FJ; Rodríguez N; Guijarro M; Espigado I; Núñez-Roldán A; Pérez-Simón JA; Aguilera I
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1356-62. PubMed ID: 24844856
[TBL] [Abstract][Full Text] [Related]
32. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
33. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
34. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
35. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
Artz AS; Wickrema A; Dinner S; Godley LA; Kocherginsky M; Odenike O; Rich ES; Stock W; Ulaszek J; Larson RA; van Besien K
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1209-16. PubMed ID: 18940674
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.
Banning U; Lange T; Krahl R; Mauz-Körholz C; Krutmann J; Niederwieser D; Körholz D
Bone Marrow Transplant; 2005 Apr; 35(7):691-7. PubMed ID: 15696178
[TBL] [Abstract][Full Text] [Related]
38. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
[TBL] [Abstract][Full Text] [Related]
39. Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.
Johnston L
Best Pract Res Clin Haematol; 2008 Jun; 21(2):177-92. PubMed ID: 18503985
[TBL] [Abstract][Full Text] [Related]
40. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhang X; Zhou Y; Xu L; Han W; Chen H; Chen Y; Fu H; Zhou S; Zhao J; Wang Q; Feng F; Zhu X; Liu K; Huang X
Ann Hematol; 2015 May; 94(5):837-45. PubMed ID: 25512184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
